| Mrs Brenda Marie Gendron, | |
|
21 Kimberly Lane, Easthampton, MA 01027-2631 | |
| (413) 527-4276 | |
| Not Available |
| Full Name | Mrs Brenda Marie Gendron |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 21 Kimberly Lane, Easthampton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780934620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | LN52300 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Brenda Marie Gendron, 21 Kimberly Ln, Easthampton, MA 01027-2631 Ph: (413) 527-4276 | Mrs Brenda Marie Gendron, 21 Kimberly Lane, Easthampton, MA 01027-2631 Ph: (413) 527-4276 |
News Archive
Enzymes bring significant benefits to laundry and cleaning products, including improved cleaning efficiencies. An updated publication from the American Cleaning Institute provides a framework for consumer product manufacturers to develop appropriate risk management strategies to avoid unacceptable risks to the users of new products containing enzymes.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR and Her2 inhibitor, was published online in the Journal of Medicinal Chemistry and also will be published in an upcoming print version of the journal.
A new study links fetal exposure to a common chemical pollutant, bisphenol A (BPA), to defects of a testicular hormone in newborn boys with undescended testicles. The results, which were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco, suggest yet another potential harmful effect of BPA, which is widely used in many plastics, liners of food cans and dental sealants.
Scientists have developed a way to produce three-dimensional X-ray images of the breast at a radiation dose that is lower than the 2D radiography methods used in clinics today. The new method enables the production of 3D diagnostic computed tomography (CT) images with a spatial resolution 2-3 times higher than present hospital scanners, but with a radiation dose that is about 25 times lower.
Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2011.
› Verified 7 days ago